Xianshuo Cheng
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Cancer, Lipids, and Metabolism 3
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 5
- Colorectal Cancer Surgical Treatments 5
- Cytokine Signaling Pathways and Interactions 4
- Chemokine receptors and signaling 3
-
- Cancer Research and Treatments 3
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited States
In The Last Decade
Xianshuo Cheng
24 papers receiving 550 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 211
- Oncology 250
- Immunology 133
- Molecular Biology 244
- Hepatology 27
Countries citing papers authored by Xianshuo Cheng
This map shows the geographic impact of Xianshuo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianshuo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianshuo Cheng more than expected).
Fields of papers citing papers by Xianshuo Cheng
This network shows the impact of papers produced by Xianshuo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianshuo Cheng. The network helps show where Xianshuo Cheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianshuo Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 5 | |
| 13 | Curative efficacy of bifidobacterium triple viable capsule combined with oxaliplatin in treatment of postoperative colorectal cancer and its effects on intestinal flora and immune function | 2019 | 1 |
| 14 | 2019 | 13 | |
| 15 | 2018 | 33 | |
| 16 | 2017 | 63 | |
| 17 | 2015 | 80 | |
| 18 | 2014 | 101 | |
| 19 | 2013 | 2 | |
| 20 | 2013 | 21 |
About Xianshuo Cheng
Xianshuo Cheng is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 26 papers that have together received 552 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Cancer Research and Treatments (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Cancer Research (211 citations), Oncology (250 citations) and Immunology (133 citations). Xianshuo Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Zhibin Yang, Cuifeng Xia, Tao Shen, Haihua Qian, Bin Sun, Yunfeng Li, Qiang Li, Yunfeng Li, Zhengfeng Yin and Xiaofeng Zhang. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.